It would seem the Volition test may have a higher sensitivity detecting stage 1 cancer (80% vs 58% for ColoStat) but, with a lower specificity (78% vs 95% for ColoStat). My basic understanding is that this means Volition can identify cancer more accurately than Colostat (80% vs 58%), however, ColoStat is better at correctly identifying patients who DON'T have the cancer 95% of the time vs 78%).
The interim results demonstrated that a small panel of three ELISA assays, when considered with the subjects' ages and smoking histories, produced an area under the curve (AUC) of 83% and was able to detect 80% of Stage I CRC cases and 66% of High-Risk Adenomas (HRA) at 78% specificity, respectively.
https://volitionrx.com/news/press-r...0-subject-clinical-trial-in-colorectal-cancer
- Forums
- ASX - By Stock
- RHY
- Competition?
Competition?, page-4
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 10.0¢ | $5.166K | 51.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 164195 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 164195 | 0.100 |
3 | 32140 | 0.098 |
1 | 5500 | 0.095 |
1 | 20000 | 0.094 |
2 | 120754 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 10000 | 1 |
0.110 | 123078 | 4 |
0.115 | 150000 | 1 |
0.120 | 52917 | 3 |
0.130 | 13636 | 1 |
Last trade - 15.43pm 18/10/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |